Erste Group Bank lowers FY2027 EPS estimate for Novartis
1 report, 1 independent
Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Erste Group Bank reduced its earnings per share estimates for Novartis' fiscal year 2027. The firm's new estimate is $9.80 per share, which is a minor reduction from the prior estimate of $9.81 per share. The consensus estimate for Novartis' full-year earnings currently stands at $8.91 per share.
From themarketsdaily.com
Why it matters
The adjustment to the earnings per share forecast affects investor expectations regarding Novartis' future profitability. The report also noted that Novartis reported $2.41 EPS and $14.95 billion in revenue for the quarter ending June 30th.
From themarketsdaily.com
Who's involved
- NovartisSwiss-American multinational pharmaceutical corporation whose earnings estimates were adjusted
Keep exploring
The entities involved
-
Novartis
Swiss-American multinational pharmaceutical corporation